| 1 |
nonalcoholic steatohepatitis
(7999 times)
|
Gastroenterology
(2260 times)
|
NAFLD (3485 times)
HCC (719 times)
MCD (407 times)
|
1989 Nonalcoholic steatohepatitis: a study of 49 patients.
|
| 2 |
nonalcoholic fatty liver disease
(6 times)
|
Physiology
(2 times)
|
4-HNE (1 time)
CA (1 time)
CD74 (1 time)
|
2014 Physiologically realistic and validated mathematical liver model reveals [corrected] hepatobiliary transfer rates for Gd-EOB-DTPA using human DCE-MRI data.
|
| 3 |
NAFLD and steatohepatitis
(5 times)
|
Food
(2 times)
|
NAFLD (5 times)
HYF (1 time)
INR (1 time)
|
2004 Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
|
| 4 |
National Audit of Seizure management in Hospitals
(5 times)
|
Neurology
(2 times)
|
EDs (2 times)
CAPS (1 time)
SUS (1 time)
|
2015 National Audit of Seizure management in Hospitals (NASH): results of the national audit of adult epilepsy in the UK.
|
| 5 |
nonalcoholic hepatic steatosis and steatohepatitis
(4 times)
|
Pathology
(2 times)
|
NAFLD (3 times)
ER (1 time)
FABP3 (1 time)
|
2008 Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
|
| 6 |
NAFLD can progress to steatohepatitis
(3 times)
|
Endocrine System Diseases
(1 time)
|
NAFLD (3 times)
HFD (1 time)
MVs (1 time)
|
2017 Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
|
| 7 |
NASH group
(3 times)
|
Microbiology
(1 time)
|
BDM-X (2 times)
HCC (2 times)
FPG (1 time)
|
2011 Impact of glucose tolerance on the severity of non-alcoholic steatohepatitis.
|
| 8 |
non-acute subdural haematomas
(3 times)
|
Neurosurgical Procedures
(1 time)
|
GOS (1 time)
|
2019 Factors influencing the results of surgical therapy of non-acute subdural haematomas.
|
| 9 |
non-alcoholic fatty liver disease and steatohepatitis
(3 times)
|
Gastroenterology
(1 time)
|
APRI (1 time)
FIB-4 (1 time)
HFD (1 time)
|
2017 Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
|
| 10 |
nonalcoholic hepatitis
(3 times)
|
Neoplasms
(1 time)
|
ER (1 time)
HCC (1 time)
HFD (1 time)
|
2016 Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health.
|
| 11 |
nucleic acid spot hybridization
(3 times)
|
Biochemistry
(1 time)
|
PCR (2 times)
BBTD (1 time)
BBTV (1 time)
|
2009 Detection of Huanglongbing (citrus greening) disease by nucleic acid spot hybridization.
|
| 12 |
NAFLD progresses from benign steatosis to steatohepatitis
(2 times)
|
Biochemistry
(1 time)
|
NAFLD (2 times)
ASOs (1 time)
FSP27 (1 time)
|
2017 Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate.
|
| 13 |
nearest accessible specialist hospital
(2 times)
|
Pulmonary Medicine
(1 time)
|
NSCLC (2 times)
|
2014 Survival of Australian lung cancer patients and the impact of distance from and attendance at a thoracic specialist centre: a data linkage study.
|
| 14 |
non-alcoholic hepatosteatosis
(2 times)
|
Fibrosis
(1 time)
|
ATP (1 time)
HSCs (1 time)
MAFLD (1 time)
|
2016 Activation of hepatic stellate cell in Pten null liver injury model.
|
| 15 |
non-alcoholic liver disease
(2 times)
|
Medicine
(1 time)
|
AI (1 time)
ALD (1 time)
HBV (1 time)
|
2006 [Non-alcoholic liver disease (NASH)].
|
| 16 |
North Atlantic subtropical high
(2 times)
|
|
ISV (1 time)
LLJ (1 time)
SE US (1 time)
|
2018 Investigating the causes of increased 20th-century fall precipitation over the southeastern United States.
|
| 17 |
encompasses a spectrum from simple steatosis to steatohepatitis
(1 time)
|
Medicine
(1 time)
|
DEGs (1 time)
IPA (1 time)
NAFLD (1 time)
|
2017 Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.
|
| 18 |
inflammation and steatohepatisis
(1 time)
|
Science
(1 time)
|
NAFLD (1 time)
|
2010 The traditional Japanese formula keishibukuryogan reduces liver injury and inflammation in patients with nonalcoholic fatty liver disease.
|
| 19 |
NAFLD advancing to steatohepatitis
(1 time)
|
|
EVs (1 time)
NAFLD (1 time)
|
2021 Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact.
|
| 20 |
NAFLD and its more-advanced form, steatohepatitis
(1 time)
|
Gastroenterology
(1 time)
|
CTRL (1 time)
D-NASH (1 time)
FAO (1 time)
|
2022 Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD.
|
| 21 |
NAFLD and nonalcoholic hepatic steatohepatitis
(1 time)
|
Endocrinology
(1 time)
|
NAFLD (1 time)
|
2022 Low levels of osteocalcin, but not CTX or P1NP, are associated with nonalcoholic hepatic steatosis and steatohepatitis.
|
| 22 |
NAFLD includes fatty liver alone or steatohepatitis
(1 time)
|
Anatomy
(1 time)
|
NAFD (1 time)
|
2002 The clinicopathologic spectrum and management of nonalcoholic fatty liver disease.
|
| 23 |
NAFLD increases the risk of disease progression to steatohepatitis
(1 time)
|
Endocrinology
(1 time)
|
DPP-4 (1 time)
GLP-1RAs (1 time)
NAFLD (1 time)
|
2020 Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease.
|
| 24 |
NAFLD ranges from simple fatty liver to steatohepatitis
(1 time)
|
Pharmacology
(1 time)
|
HCC (1 time)
NAFLD (1 time)
|
2005 The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
|
| 25 |
NAFLD with inflammatory features
(1 time)
|
Food
(1 time)
|
BPF (1 time)
CAF (1 time)
IL-6 (1 time)
|
2018 Bergamot Polyphenols Boost Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis (NASH) Induced by "Junk Food": Evidence for Anti-Inflammatory Activity.
|
| 26 |
NAFLD, and its more severe form with steatohepatitis
(1 time)
|
Endocrinology
(1 time)
|
IR (1 time)
|
2014 High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
|
| 27 |
NAFLD, but can progress in some patients to advanced steatohepatitis
(1 time)
|
Gastroenterology
(1 time)
|
BIA (1 time)
CVD (1 time)
MS (1 time)
|
2016 Patients with ultrasound diagnosis of hepatic steatosis are at high metabolic risk.
|
| 28 |
NAFLD, steatosis and steatohepatitis
(1 time)
|
Biochemistry
(1 time)
|
NAFLD (1 time)
|
2010 Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?
|
| 29 |
NAFLD; lowest levels were observed in those with severe steatosis
(1 time)
|
Diabetes Mellitus
(1 time)
|
CLA (1 time)
|
2019 Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link?
|
| 30 |
namely steatohepatitis
(1 time)
|
Gastroenterology
(1 time)
|
NAFLD (1 time)
|
2012 Nonalcoholic fatty liver disease in Asia: a story of growth.
|
| 31 |
NASH and advanced fibrosis
(1 time)
|
Endocrinology
(1 time)
|
AUCs (1 time)
NAFLD (1 time)
T2DM (1 time)
|
2019 Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.
|
| 32 |
NASH patients
(1 time)
|
Gastrointestinal Diseases
(1 time)
|
LP (1 time)
MTTs (1 time)
NAFLD (1 time)
|
2014 CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
|
| 33 |
NASH-HCC
(1 time)
|
Transplantation
(1 time)
|
HCC (1 time)
LT (1 time)
|
2018 Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma.
|
| 34 |
National Alliance for Safe Housing
(1 time)
|
Spouse Abuse
(1 time)
|
---
|
2021 Identifying and Responding to the Complex Needs of Domestic Violence Housing Practitioners at the Onset of the COVID-19 Pandemic.
|
| 35 |
nations and ranges in severity from steatosis to steatohepatitis
(1 time)
|
Chemistry
(1 time)
|
NAFLD (1 time)
Nrf2 (1 time)
ROS (1 time)
|
2019 Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction.
|
| 36 |
natural, accidental, suicidal, or homicidal
(1 time)
|
Health Services
(1 time)
|
HCP (1 time)
|
2016 Improving the support of the suddenly bereaved.
|
| 37 |
necroinflammatory steatohepatitis
(1 time)
|
Gastroenterology
(1 time)
|
CAD (1 time)
miRNAs (1 time)
NAFLD (1 time)
|
2016 Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease.
|
| 38 |
non-alcoholic fatty liver disease progression towards steatohepatitis
(1 time)
|
Antioxidants
(1 time)
|
Glrx (1 time)
|
2022 Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis.
|
| 39 |
non-alcoholic steatohepatitis and cirrhosis
(1 time)
|
Immune System Diseases
(1 time)
|
HCC (1 time)
NAFL (1 time)
NAFLD (1 time)
|
2021 Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns.
|
| 40 |
non-Ashkenazi
(1 time)
|
Allergy and Immunology
(1 time)
|
AChR (1 time)
ASH (1 time)
MG (1 time)
|
2017 Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel.
|
| 41 |
non-invasive identification of steatohepatitis
(1 time)
|
Gastroenterology
(1 time)
|
ION (1 time)
LS (1 time)
NPV (1 time)
|
2017 Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study.
|
| 42 |
non-invasive methods to detect steatohepatitis
(1 time)
|
Natural Science Disciplines
(1 time)
|
AUROC (1 time)
GE (1 time)
MR (1 time)
|
2016 Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease.
|
| 43 |
Non-linear Attentional Saturation Hypothesis
(1 time)
|
Nervous System Diseases
(1 time)
|
fMRI (1 time)
|
2018 Network Dynamics of Attention During a Naturalistic Behavioral Paradigm.
|
| 44 |
non-NASH
(1 time)
|
General Surgery
(1 time)
|
BMI (1 time)
HCV (1 time)
|
2018 Clinical Characteristics and Outcome of Morbidly Obese Bariatric Patients with Concurrent Hepatitis C Viral Infection.
|
| 45 |
non-steatohepatitis
(1 time)
|
Medicine
(1 time)
|
NAFLD (1 time)
|
2020 Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD.
|
| 46 |
nonalcoholic fatty liver diseases and more advanced steatohepatitis
(1 time)
|
Cell Biology
(1 time)
|
DKO (1 time)
PRDX4 (1 time)
SOD1 (1 time)
|
2018 Double Knockout of Peroxiredoxin 4 (Prdx4) and Superoxide Dismutase 1 (Sod1) in Mice Results in Severe Liver Failure.
|
| 47 |
nonalcoholic fatty liver hepatitis or steatohepatitis
(1 time)
|
Digestive System Surgical Procedures
(1 time)
|
MAFLD (1 time)
NAFL (1 time)
NAFLD (1 time)
|
2021 Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD).
|
| 48 |
Norwegian summer-autumn spawning herring
(1 time)
|
Science
(1 time)
|
NSAH (1 time)
NSSH (1 time)
|
2017 Oogenesis and reproductive investment of Atlantic herring are functions of not only present but long-ago environmental influences as well.
|
| 49 |
number of affected relatives, age, smoking, and hypertension
(1 time)
|
Brain
(1 time)
|
IAs (1 time)
|
2022 Number of Affected Relatives, Age, Smoking, and Hypertension Prediction Score for Intracranial Aneurysms in Persons With a Family History for Subarachnoid Hemorrhage.
|
| 50 |
Nutrition and Activity Self-History
(1 time)
|
Obesity
(1 time)
|
ReCAP (1 time)
WIC (1 time)
|
2013 Innovative tools help counselors discuss childhood obesity with parents.
|
| 51 |
only a small proportion of these patients develop steatohepatitis
(1 time)
|
Gastroenterology
(1 time)
|
Hh (1 time)
|
2012 Mechanisms of disease progression in NASH: new paradigms.
|
| 52 |
Questionnaire-nonalcoholic steatohepatitis
(1 time)
|
Gastroenterology
(1 time)
|
NAFLD (1 time)
PROs (1 time)
|
2021 Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.
|
A Search Service for Abbreviation / Long Form